Portfolio Holdings Detail for ISIN IE000KJPDY61
Stock Name / FundiShares World Equity High Income UCITS ETF USD Inc
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity Type
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWINC(GBP) LSE
ETF TickerWINC.AS(USD) AS
ETF TickerWINC(USD) Euronext Amsterdam

Holdings detail for MRK

Stock NameMarks Electrical Group PLC
TickerMRK(GBX) LSE
TYPECommon Stock
CountryUK
ISINGB00BM8Q5G47
LEI2138007KN8TKPIXIQE92
TickerMRK(EUR) F

Show aggregate MRK holdings

News associated with MRK

Surprising Analyst 12-Month Target For FDL
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 08:04:45
IWD, JNJ, MCD, MRK: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Value ETF (Symbol: IWD) where we have detected an approximate $565.9 million dollar inflow -- that's a 0.9% increase week over w - 2025-09-18 13:26:06
Daiichi Sankyo, Merck Say Raludotatug Deruxtecan Granted Breakthrough Therapy Designation
(RTTNews) - Daiichi Sankyo Company Limited (DSKYF) and Merck & Co Inc. (MRK) said on Monday that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for their raludotatug deruxtecan for the treatment of adults with platinum-resistant epithelia - 2025-09-15 08:43:59
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-12 10:32:51
Guru Fundamental Report for MRK - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-11 10:33:21
Notable ETF Inflow Detected - VYM, JNJ, MRK, CME
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard High Dividend Yield ETF (Symbol: VYM) where we have detected an approximate $440.7 million dollar inflow -- that's a 0.7% increase week over - 2025-09-10 11:50:46
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-10 10:34:14
Daiichi Sankyo And Merck : Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial
(RTTNews) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated clinically meaningful response rates in patients with previously treated extensive-stage small c - 2025-09-08 02:18:22
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-05 10:33:56
Pre-Market Most Active for Sep 5, 2025 : OPEN, TSLL, SCAG, SQQQ, MRK, NVDA, KO, AVGO, SNAP, FIG, WMT, NIO
The NASDAQ 100 Pre-Market Indicator is up 147.96 to 23,780.97. The total Pre-Market volume is currently 100,628,631 shares traded.The following are the most active stocks for the pre-market session: Opendoor Technologies Inc (OPEN) is +0.27 at $6.23, with 12,819,663 shares trade - 2025-09-05 09:29:53
Guru Fundamental Report for MRK - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-04 10:32:25
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-09-03 10:34:47
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-29 10:33:23
MRK's Strong Dividend History Helps it Reach 'Top Dividend Stock of the Dow'
Merck & Co Inc (Symbol: MRK) has been named as the ''Top Dividend Stock of the Dow'', according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among the components of the Dow Jones Industrial Average, MRK shares displayed b - 2025-08-28 08:50:04
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-27 10:34:49
MRK Quantitative Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-26 10:34:02
iShares MSCI ACWI ETF Experiences Big Outflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares MSCI ACWI ETF (Symbol: ACWI) where we have detected an approximate $429.5 million dollar outflow -- that's a 1.9% decrease week over week (f - 2025-08-25 13:36:45
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-22 10:34:21
Dow Movers: WMT, MRK
In early trading on Thursday, shares of Merck topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Merck has lost about 13.8% of its value. And the worst performing Dow component thus far on the day is Walmart, tr - 2025-08-21 11:27:42
MRK Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-20 10:34:00
After Hours Most Active for Aug 19, 2025 : CSX, INTC, MRK, NVDA, IBN, KO, FUN, PEP, CX, WMT, HTZ, QQQ
The NASDAQ 100 After Hours Indicator is down -1.71 to 23,383.06. The total After hours volume is currently 259,932,235 shares traded.The following are the most active stocks for the after hours session: CSX Corporation (CSX) is -0.04 at $36.48, with 11,794,785 shares traded. Ove - 2025-08-19 17:24:59
Daiichi Sankyo Announces Breakthrough Therapy Designation For Ifinatamab Deruxtecan
(RTTNews) - Daiichi Sankyo announced that Ifinatamab deruxtecan has been granted Breakthrough Therapy Designation by the FDA for the treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. The FDA g - 2025-08-18 08:36:51
The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey
Analysts spotlight Merck, Palo Alto Networks, Freeport-McMoRan, and Espey as innovation, contract wins, and industry trends shape growth prospects. - 2025-08-15 12:44:00
Noteworthy ETF Outflows: SUSL, MCD, DIS, MRK
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares ESG MSCI USA Leaders ETF (Symbol: SUSL) where we have detected an approximate $84.6 million dollar outflow -- that's a 8.7% decrease week ov - 2025-08-15 11:49:25
Peter Lynch Detailed Fundamental Analysis - MRK
Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati - 2025-08-15 10:31:59
Top Analyst Reports for Merck, Palo Alto & Freeport
Merck leans on Keytruda growth and pipeline expansion, Palo Alto rides subscription security demand, and Freeport benefits from electrification-driven copper demand. - 2025-08-14 17:46:00
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 15:15:33
MRK April 2026 Options Begin Trading
Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contra - 2025-08-14 14:30:24
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 14:05:26
Stocks See Support As Bessent Calls for a Big Rate Cut
The S&P 500 Index ($SPX ) (SPY ) on Wednesday rose +0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.04%. September E-mini S&P futures (ESU25 ) rose +0.32%, and September E-mini Nasdaq futures (NQU25 ) fell... - 2025-08-14 12:17:47

iShares World Equity High Income UCITS ETF USD Inc MRK holdings

DateNumber of MRK Shares HeldBase Market Value of MRK SharesLocal Market Value of MRK SharesChange in MRK Shares HeldChange in MRK Base ValueCurrent Price per MRK Share HeldPrevious Price per MRK Share Held
2025-12-12 (Friday)249MRK holding increased by 1USD 24,975MRK holding increased by 421USD 24,9751USD 421 USD 100.301 USD 99.0081
2025-12-11 (Thursday)248USD 24,554MRK holding increased by 344USD 24,5540USD 344 USD 99.0081 USD 97.621
2025-12-10 (Wednesday)248USD 24,210MRK holding increased by 181USD 24,2100USD 181 USD 97.621 USD 96.8911
2025-12-09 (Tuesday)248USD 24,029USD 24,029
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MRK by Blackrock for IE000KJPDY61

Show aggregate share trades of MRK

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-12BUY1100.66098.315 98.550GBX 99 86.09
2025-11-18SELL-1,21097.66092.110 92.665GBX -112,125 85.68 Loss of -8,455 on sale
2025-10-07SELL-2,22588.94087.140 87.320GBX -194,287 85.43 Loss of -4,215 on sale
2025-09-30SELL-57884.00078.400 78.960GBX -45,639 85.33 Profit of 3,684 on sale
2025-09-26SELL-37178.96077.694 77.821GBX -28,872 85.42 Profit of 2,820 on sale
2025-08-11BUY7281.64079.630 79.831GBX 5,748 85.49
2025-08-07BUY2480.82078.650 78.867GBX 1,893 85.55
2025-08-04BUY4879.99078.430 78.586GBX 3,772 85.67
2025-07-25BUY2485.22083.840 83.978GBX 2,015 85.83
2025-07-24BUY2484.51083.520 83.619GBX 2,007 85.84
2025-07-23BUY2484.14082.410 82.583GBX 1,982 85.85
2025-07-22BUY4881.77079.870 80.060GBX 3,843 85.88
2025-07-18BUY7281.92079.860 80.066GBX 5,765 85.98
2025-07-17BUY7282.66081.340 81.472GBX 5,866 86.01
2025-07-16BUY12082.64081.460 81.578GBX 9,789 86.03
2025-07-15BUY4884.36081.300 81.606GBX 3,917 86.07
2025-07-14BUY7284.30083.110 83.229GBX 5,992 86.09
2025-07-11BUY2484.13082.260 82.447GBX 1,979 86.11
2025-07-09BUY4884.48081.890 82.149GBX 3,943 86.14
2025-07-07BUY9681.54080.150 80.289GBX 7,708 86.22
2025-07-02SELL-76182.79081.894 81.983GBX -62,389 86.33 Profit of 3,310 on sale
2025-06-24SELL-1,16581.46079.090 79.327GBX -92,416 86.62 Profit of 8,494 on sale
2025-06-23BUY3680.22078.990 79.113GBX 2,848 86.67
2025-06-17SELL-2,09380.70078.190 78.441GBX -164,177 86.94 Profit of 17,783 on sale
2025-06-13BUY24582.44081.450 81.549GBX 19,980 87.04
2025-06-12BUY4982.11080.070 80.274GBX 3,933 87.08
2025-06-11BUY3681.68079.980 80.150GBX 2,885 87.14
2025-06-10BUY2,05181.88079.330 79.585GBX 163,229 87.19
2025-06-04BUY7279.14077.330 77.511GBX 5,581 87.52
2025-06-03BUY21677.18575.435 75.610GBX 16,332 87.62
2025-06-02BUY36 76.250* 87.72
2025-05-28BUY3677.72575.590 75.803GBX 2,729 88.05
2025-05-21BUY28878.10076.870 76.993GBX 22,174 88.60
2025-05-16BUY3676.16574.368 74.547GBX 2,684 88.97
2025-05-09BUY144 75.970* 89.68
2025-05-06BUY72 79.040* 90.07
2025-04-29BUY3685.69082.750 83.044GBX 2,990 90.45
2025-04-09BUY18081.99076.000 76.599GBX 13,788 92.78
2025-04-04BUY3686.26081.090 81.607GBX 2,938 93.36
2025-03-26BUY85 88.110* 93.90
2025-03-25BUY2,472 87.870* 94.01
2025-03-19BUY17 94.020* 94.05
2025-03-14BUY51 94.570* 94.01
2025-03-04BUY562 92.560* 94.00
2025-02-26BUY3391.37088.860 89.111GBX 2,941 94.27
2025-02-25BUY11093.06090.440 90.702GBX 9,977 94.34
2025-02-18BUY2283.59081.040 81.295GBX 1,788 95.39
2025-02-11SELL-25986.99085.730 85.856GBX -22,237 97.33 Profit of 2,971 on sale
2025-02-10BUY2687.98086.270 86.441GBX 2,247 97.73
2025-02-04SELL-57491.23087.330 87.720GBX -50,351 99.26 Profit of 6,624 on sale
2025-01-28SELL-81298.88096.590 96.819GBX -78,617 99.43 Profit of 2,117 on sale
2025-01-27BUY2698.62095.990 96.253GBX 2,503 99.51
2025-01-22BUY10497.00095.150 95.335GBX 9,915 100.28
2025-01-15SELL-90100.82099.618 99.738GBX -8,976 101.22 Profit of 134 on sale
2025-01-14BUY54101.49099.020 99.267GBX 5,360 101.42
2025-01-10BUY54100.40598.810 98.969GBX 5,344 101.86
2025-01-08SELL-491100.77098.060 98.331GBX -48,281 102.86 Profit of 2,223 on sale
2025-01-08SELL-491100.77098.060 98.331GBX -48,281 102.86 Profit of 2,223 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MRK

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-191,053,2942,0243,869,11627.2%
2025-09-181,184,9228,0053,015,34039.3%
2025-09-171,616,76818,7303,647,85344.3%
2025-09-161,223,7119603,598,70934.0%
2025-09-151,814,7678,4204,295,96242.2%
2025-09-122,018,4637,5573,506,69457.6%
2025-09-111,493,7285,3993,180,82847.0%
2025-09-102,013,1025,3353,313,84760.7%
2025-09-091,075,1375,5052,373,81745.3%
2025-09-082,147,2042,4483,731,34357.5%
2025-09-051,440,1149,9482,983,29648.3%
2025-09-041,439,7261,1215,661,88725.4%
2025-09-031,849,1033,5534,699,60739.3%
2025-09-022,193,136115,1354,314,82650.8%
2025-08-291,545,05711,4203,841,71540.2%
2025-08-281,559,7666,1695,284,88829.5%
2025-08-271,383,4767,8383,737,50637.0%
2025-08-261,328,2351,2292,869,94446.3%
2025-08-252,177,2005,5783,771,31357.7%
2025-08-221,523,3527,4973,248,57546.9%
2025-08-212,449,66018,5405,416,96945.2%
2025-08-201,189,29116,6923,133,34538.0%
2025-08-191,722,6512,3313,737,68946.1%
2025-08-181,150,9372,8222,604,34444.2%
2025-08-151,795,3941,6733,415,80852.6%
2025-08-142,198,5622,2724,496,39848.9%
2025-08-131,885,48019,5373,953,04547.7%
2025-08-121,593,84410,3603,185,66750.0%
2025-08-11990,4053,6052,886,69034.3%
2025-08-081,224,37811,1872,672,27945.8%
2025-08-071,718,6615,3564,504,85038.2%
2025-08-062,028,9271,8824,007,25250.6%
2025-08-051,573,6816,0493,579,53444.0%
2025-08-041,568,9759443,301,80147.5%
2025-08-011,718,70113,8534,079,64242.1%
2025-07-313,367,7552,6646,082,64455.4%
2025-07-302,253,4585,8784,162,63654.1%
2025-07-295,939,07236,24911,111,79553.4%
2025-07-282,243,2356,7394,563,91349.2%
2025-07-251,302,4376,9002,889,20745.1%
2025-07-241,156,3972,5702,732,35142.3%
2025-07-231,879,40020,2804,001,02547.0%
2025-07-221,628,7541,7733,592,84745.3%
2025-07-211,900,56312,5715,188,43236.6%
2025-07-181,536,7621,2463,463,05944.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.


Copyright Market Footprint Ltd. Privacy Policy